ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "axial spondyloarthritis and rheumatoid arthritis (RA)"

  • Abstract Number: 31 • ACR/ARHP Annual Meeting 2016

    Patients with Either Rheumatoid Arthritis (RA) or Axial Spondyloarthritis (axSpA) Self-Reported Flares in 24% of Assessments: An Observational Study of 86 Patients Assessed Weekly over 3 Months (ie, 1,100 assessments)

    Charlotte Jacquemin1, Herve Servy2, Anna Molto3, Jeremie Sellam4, Violaine Foltz1, Frédérique Gandjbakhch1, Christophe Hudry3, Stéphane Mitrovic1, Bruno Fautrel1 and Laure Gossec1, 1Rheumatology, Pitié Salpêtrière Hospital, Paris, France, 2Sanoia, La Ciotat, France, 3Rheumatology, Cochin Hospital, Paris, France, 4Rheumatology, Saint-Antoine Hospital, Paris, France

    Background/Purpose:  The evolution of RA and axSpA is characterized by alternated periods of flares and remission. This fluctuating disease activity can be self-assessed by a…
  • Abstract Number: 9 • ACR/ARHP Annual Meeting 2015

    Serum Visfatin Levels in Patients with Axial Spondyloarthitis and Early Rheumatoid Arthritis: Relation to Inflammation and Bone Changes

    Hana Hulejova1, Klára Prajzlerová2, Olga Krystufkova2, Krystýna Grobelná2, Maria Filkova2, Herman F Mann3, Karel Pavelka4, Jiri Vencovsky3 and Ladislav Senolt5, 1Institute of Rheumatology and Department of Rheumatology, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 3Institute of Rheumatology, Prague, Czech Republic, 4Charles University, Prague, Czech Republic, 5Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Visfatin may represent a novel biomarker of disease severity. Serum visfatin levels are elevated in patients with early rheumatoid arthritis (ERA) and axial spondyloarthritis…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology